BILLERICA, Mass. — SeqLL Inc. (“SeqLL”, NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced the establishment of a two-year Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Justice’s Federal Bureau of Investigation (FBI). Under this CRADA, SeqLL and the FBI Laboratory Division (FBI LD) will seek […]
Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 million […]
Comprehensive system that enables unmatched single cell multiomic analysis is now widely available following the completion of a successful Early Access Program DURHAM, N.C. –- BioSkryb Genomics, a pioneer in comprehensive single cell multiomic research solutions, today announced the commercial launch of its ResolveOME™ Whole Genome and Transcriptome Amplification system and BaseJumper™ Bioinformatics Platform at the Advances in Genome […]
Eclipsebio’s eSHAPE™ product family is a combination of kits, services, and databases, that facilitates the study of RNA secondary structure in both in vitro and in cellulo conditions SAN DIEGO — Eclipse Bioinnovations (Eclipsebio), a leading RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, today announced the launch of its eSHAPE™ suite of […]
New immune profiling and enrichment capabilities expand applications and facilitate scalability HOLLYWOOD, FLA. (AGBT GENERAL MEETING) — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercode™ TCR and Gene Capture. These new solutions expand the Parse Biosciences portfolio to address higher scale and immune profiling applications. […]
Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale CAMBRIDGE, England — EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 […]
DNBSEQ-T20x2*produces up to 50,000 WGS per year at a first sub hundred-dollar price per genome DNBSEQ-T7* offers an outstanding $1.5/Gb price for sequencing consumables DNBSEQ-G99* delivers a first-in-class PE150 run within 12 hours with a data output of 8- 48 Gb per run stLFR library prep kit enables more complete and accurate haplotype-phased genom HOLLYWOOD, […]
Technology enables scientists to isolate single cell lines three times faster and at lower cost compared to existing solutions SAN JOSE, Calif. – Molecular Devices, LLC., a leading provider of high-performance life science solutions, has entered into a partnership with SEED Biosciences Ltd, a solutions company for single-cell assays. Molecular Devices is now an exclusive commercial supplier […]
Additional sequencing applications and reference standards to be highlighted at the conference SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced technology early access of the Twist enhanced Whole Genome Sequencing (eWGS) solution focused on non-human […]
MENLO PARK, Calif. — LevitasBio, Inc. ( www.levitasbio.com ), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230207005645/en/ Five new LeviSelect Immune Cell Kits enable targeted enrichment of CD3 […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
